-transparent.png){kind=logo}
The disposition of captopril, an angiotensin-converting enzyme inhibitor with antihypertensive properties, was studied in 10 normal male subjects after a single 100-mg tablet of 35S-labeled drug. Average absorption parameters for unchanged captopril in blood were Tmax 0.93 +/- 0.08 hr and Cmax 800 +/- 76 ng/ml. For total radioactivity in blood the values were Tmax 1.05 +/- 0.08 hr and Cmax 1,580 +/- 90 ng/ml (as captopril equivalents). Because of the curvilinearity of the semilogarithmic plots of blood concentrations of captopril:time, elimination half-life (t1/2) of unchanged drug could not be determined. At 1 hr unchanged captopril accounted for about 52% of total radioactivity in blood, and the dimeric disulfide metabolite of captopril accounted for about 10%. In the first 5 days after dosing, an average of about 68% of the radioactive dose was recovered in urine and 18% in feces. The distribution of radioactivity in the first 24-hr urine sample (66% of the dose) was 58% captopril (38% of dose), 2% captopril disulfide (1.5% of dose), and 40% unidentified polar metabolites (26% of dose).
K J Kripalani, and
D N McKinstry, and
S M Singhvi, and
D A Willard, and
R A Vukovich, and
B H Migdalof
July 1971,
Annals of the New York Academy of Sciences,
K J Kripalani, and
D N McKinstry, and
S M Singhvi, and
D A Willard, and
R A Vukovich, and
B H Migdalof
January 1980,
Biopharmaceutics & drug disposition,
K J Kripalani, and
D N McKinstry, and
S M Singhvi, and
D A Willard, and
R A Vukovich, and
B H Migdalof
February 1980,
Antimicrobial agents and chemotherapy,
K J Kripalani, and
D N McKinstry, and
S M Singhvi, and
D A Willard, and
R A Vukovich, and
B H Migdalof
January 1986,
Medicinal research reviews,
K J Kripalani, and
D N McKinstry, and
S M Singhvi, and
D A Willard, and
R A Vukovich, and
B H Migdalof
June 1988,
Clinical pharmacology and therapeutics,
K J Kripalani, and
D N McKinstry, and
S M Singhvi, and
D A Willard, and
R A Vukovich, and
B H Migdalof
January 1969,
Clinical pharmacology and therapeutics,
K J Kripalani, and
D N McKinstry, and
S M Singhvi, and
D A Willard, and
R A Vukovich, and
B H Migdalof
February 1989,
Journal of clinical pharmacology,
K J Kripalani, and
D N McKinstry, and
S M Singhvi, and
D A Willard, and
R A Vukovich, and
B H Migdalof
January 1991,
Drug metabolism and disposition: the biological fate of chemicals,
K J Kripalani, and
D N McKinstry, and
S M Singhvi, and
D A Willard, and
R A Vukovich, and
B H Migdalof
January 1987,
Clinical and experimental hypertension. Part A, Theory and practice,
K J Kripalani, and
D N McKinstry, and
S M Singhvi, and
D A Willard, and
R A Vukovich, and
B H Migdalof
February 1996,
Journal of clinical pharmacology,
